Deciphera Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Deciphera Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $22.98 per share as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2024-02-07
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $22.98.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $24.26.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $29.28.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $29.53.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2023-12-31 | $22.98 10-K · filed 2024-02-07 |
| 2022-12-31 | $24.26 10-K · filed 2024-02-07 |
| 2021-12-31 | $29.28 10-K · filed 2023-02-07 |
| 2020-12-31 | $29.53 10-K · filed 2022-02-08 |
| 2019-12-31 | $19.36 10-K · filed 2021-02-09 |
| 2018-12-31 | $10.92 10-K · filed 2020-03-09 |
| 2017-12-31 | $4.99 10-K · filed 2019-03-14 |
| 2016-12-31 | $2.43 10-K · filed 2018-03-28 |